Exploratory high-throughput screening of repurposed drugs for canine lymphoid malignancies
This exploratory screening study identified clinically approved drugs with available pharmacokinetic data as candidate therapeutic agents for the treatment of canine lymphoid malignancies. Based on this study, further studies are warranted to validate the in vivo efficacy and elucidate the underlying mechanisms of candidate drugs in canine lymphoid malignancies.
Authors
- Atsushi Tsukamoto (ORCID: https://orcid.org/0000-0002-2047-4970)
- Masaki Ishida (ORCID: https://orcid.org/0000-0003-0625-0767)
- Hirotaka Tomiyasu (ORCID: https://orcid.org/0000-0001-7708-6218)
- M. Nishida
- Hiroki Sakuma
- Shinichiro Nakamura
- Emia Daiku
- Mari Takamiya
Institutions
- Azabu University (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- BMC Veterinary Research
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1186/s12917-025-05053-8
- Primary Topic
- Virus-based gene therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development
- Veterinärmedizinische Universität Wien
- Japan Society for the Promotion of Science